van Loon H J, Box A T A, Verhoef J, Fluit A C
Eijkman-Winkler Institute for Microbiology, Infectious Disease and Inflammation, University Medical Center Utrecht, Utrecht, The Netherlands.
Int J Antimicrob Agents. 2004 Aug;24(2):130-4. doi: 10.1016/j.ijantimicag.2004.01.015.
Antibiotic resistance is a major and well-known problem in intensive care units (ICUs) world-wide and previously susceptible isolates become resistant through the acquisition of resistance determinants from other bacteria or the development of mutations, as is the case in beta-lactam resistance. We evaluated the presence of resistance determinants involved in beta-lactam resistance and multi-resistance in order to establish the contribution of horizontal gene transfer to the spread of resistance in a surgical ICU during an antibiotic rotation study. Pseudomonas aeruginosa and Enterobacteriaceae isolates were selected and iso-electric focusing (IEF), DNA-typing methods such as specific beta-lactamase and specific integron PCRs were performed to determine the presence of beta-lactamases. The PCRs specific for IMP-1, OXA-1, and VIM-type beta-lactamases performed on the selected P. aeruginosa and Enterobacteriaceae isolates with MICs for cephalosporins >1 mg/l did not demonstrate any of these beta-lactamases. IEF for 14 pseudomonads, representing 7 genotypes from 9 patients, showed a beta-lactamase with a pI larger than 8.5 in 13 of the isolates. The integrase PCR was positive for only five isolates from three patients and conserved segment PCR showed integrons of variable sizes (700, 900, 1,400 and 1,500 bp). Each patient had its own integron types. It can be concluded that integrons and associated resistance determinants played only a minor role in the surgical ICU and beta-lactam resistance among P. aeruginosa isolates was most likely due to the derepression of its AmpC gene.
抗生素耐药性是全球重症监护病房(ICU)中一个主要且广为人知的问题,先前敏感的菌株会通过从其他细菌获得耐药决定因素或发生突变而产生耐药性,β-内酰胺类耐药性就是这种情况。在一项抗生素轮换研究中,我们评估了参与β-内酰胺类耐药性和多重耐药性的耐药决定因素的存在情况,以确定水平基因转移对外科ICU中耐药性传播的作用。选择了铜绿假单胞菌和肠杆菌科分离株,并进行了等电聚焦(IEF)以及DNA分型方法,如特异性β-内酰胺酶和特异性整合子PCR,以确定β-内酰胺酶的存在。对头孢菌素最低抑菌浓度(MIC)>1mg/L的所选铜绿假单胞菌和肠杆菌科分离株进行的针对IMP-1、OXA-1和VIM型β-内酰胺酶的PCR检测未显示出任何这些β-内酰胺酶。对来自9名患者的7种基因型的14株假单胞菌进行IEF分析,结果显示13株分离株中有一株β-内酰胺酶的等电点大于8.5。整合酶PCR仅对来自三名患者的五株分离株呈阳性,保守片段PCR显示出大小可变的整合子(700、900、1400和1500bp)。每位患者都有其自己的整合子类型。可以得出结论,整合子及相关耐药决定因素在外科ICU中仅起次要作用,铜绿假单胞菌分离株中的β-内酰胺类耐药性很可能是由于其AmpC基因的去阻遏作用。